IDEAYA Biosciences, Inc. (IDYA), a clinical-stage oncology company, on Tuesday announced the appointment of Yujiro S. Hata as Chairman of the Board by its Board of Directors.
Hata currently serves as the President and Chief Executive Officer, and a member of IDEAYA's Board.
Terry Rosen has been appointed as the Lead Independent Director of IDEAYA's Board.
IDEAYA shares closed Tuesday at $30.57, up 1.12%. In the pre-market, shares are trading at $30.50, down 0.23%.
For more such biotech stock news, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.